Profilo
Anton Hoos currently works at Cy Biopharma AG, as Chief Executive Officer and Patient Focused Medicine Development, as Director from 2014.
Dr. Hoos also formerly worked at CSL Behring GmbH, as Vice President and Swedish Orphan Biovitrum AB, as Chief Medical Officer, Head-Medical Affairs, R&D in 2023.
Dr. Hoos received his Masters Business Admin degree from the University of Toronto and doctorate degree from Ludwig-Maximilians-Universität München.
Posizioni attive di Anton Hoos
| Società | Posizione | Inizio |
|---|---|---|
Patient Focused Medicine Development | Direttore/Membro del Consiglio | 01/01/2014 |
Precedenti posizioni note di Anton Hoos
| Società | Posizione | Fine |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Direttore Tecnico/Scientifico/R&S | 19/06/2023 |
Cy Biopharma AG
Cy Biopharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotech platform generating novel psychedelic molecules for breakthrough therapeutics | Amministratore Delegato | - |
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Corporate Officer/Principal | - |
Formazione di Anton Hoos
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Patient Focused Medicine Development | |
Cy Biopharma AG
Cy Biopharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotech platform generating novel psychedelic molecules for breakthrough therapeutics | Commercial Services |
















